LF
ABBV icon

Lansforsakringar Fondforvaltning’s AbbVie ABBV Stock Holding History

Lansforsakringar Fondforvaltning’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$123M Sell
566,186
-39,973
-7% -$8.87M 0.64% 19
2025
Q4 		$139M Buy
606,159
+49,661
+9% +$11.3M 0.69% 19
2025
Q3 		$129M Buy
556,498
+14,162
+3% +$2.88M 0.67% 20
2025
Q2 		$101M Sell
542,336
-27,733
-5% -$5.15M 0.58% 26
2025
Q1 		$119M Sell
570,069
-17,141
-3% -$3.33M 0.73% 22
2024
Q4 		$104M Buy
+587,210
New +$108M 0.58% 27

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Lansforsakringar Fondforvaltning's ABBV Position: Q1 2026 in Review

Lansforsakringar Fondforvaltning reduced its AbbVie (ABBV) stake by 6.6% in Q1 2026, selling an estimated $8.87M and leaving 566,186 shares worth $123M. The position accounts for 0.64% of the portfolio, ranked #19.

Lansforsakringar Fondforvaltning first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. The position peaked at $139M in Q4 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Lansforsakringar Fondforvaltning held 566,186 shares of AbbVie worth $123M as of Q1 2026.
  • Lansforsakringar Fondforvaltning sold 39,973 AbbVie shares in Q1 2026, an estimated $8.87M.
  • AbbVie made up 0.64% of Lansforsakringar Fondforvaltning's portfolio in Q1 2026, its #19 holding.
  • Lansforsakringar Fondforvaltning first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
  • Lansforsakringar Fondforvaltning's AbbVie position peaked at $139M in Q4 2025.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Lansforsakringar Fondforvaltning's 13F filing for Q1 2026, filed 23 Apr 2026.